MADISON, N.J., June 20 /PRNewswire-FirstCall/ -- Wyeth announced today that the jury in the case of Virginia Cavender v. Wyeth, in the U.S. District Court for the Eastern District of Missouri in St. Louis, returned a verdict in favor of the plaintiff in the amount of $75,000.
The trial began on June 11, 2007 before The Honorable E. Richard Webber. The plaintiff alleged heart valve injury from the use of the diet drug Pondimin, a drug once marketed by Wyeth. The Company is reviewing its post- trial options.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products and nonprescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
Wyeth
CONTACT: Media, Douglas Petkus, +1-973-660-5218, or Investors, JustinVictoria, +1-973-660-5340, both of Wyeth
Web site: http://www.wyeth.com/
